Concord Biotech commences production of injectable at Valthera facility

25 Mar 2025 Evaluate

Concord Biotech has successfully commissioned and commenced production of injectable at its new manufacturing facility situated at Valthera. This advanced facility has been designed and constructed to adhere to stringent international standards, equipped with cutting-edge technology to ensure the consistent delivery of high-quality products. The operationalization of Unit-4 is a part of company's strategic growth initiatives.

Concord Biotech is an India-based biopharma company and one of the leading global developers and manufacturers of select fermentation-based APIs across Immunosuppressants and oncology. 


Concord Biotech Share Price

1643.45 -14.40 (-0.87%)
27-Mar-2025 09:32 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1725.20
Dr. Reddys Lab 1154.00
Cipla 1468.75
Lupin 2021.00
Zydus Lifesciences 890.90
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Please wait your portfolio is updating...